How many employees does Ennogen Pharma Ltd have?

Ennogen Pharma Ltd reported an average of 2 employees in the year to 31 Dec 2022.

Is Ennogen Pharma Ltd profitable?

Yes — Ennogen Pharma Ltd reported a profit of £603k in the year to 31 Dec 2022.

Company No. 07751819 · Incorporated 24 Aug 2011

Ennogen Pharma Ltd

Registered name: ENNOGEN PHARMA LTD

Ennogen Pharma Ltd made £603k profit in the year to 31 Dec 2022 (revenue not disclosed).

Ennogen Pharma Ltd reported £603k profit in the year to 31 Dec 2022, up 625% on the year before; its revenue was not disclosed. It had 2 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Dartford; we hold 2 years of its filed accounts.

Profit onlySection C · ManufacturingSIC 21100Manufacture of basic pharmaceutical products SIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Dartford, South East
Age: 15 yrs · since 2011
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2022

Key figures

Small team

Revenue

—

Not disclosed in filing

Profit

£603k

Growth ▲625.4%

Profit margin

—

Employees

Change ▼50%

Profit / employee

£302k

Profitable streak

2yrs

Consecutive profitable years in our data

This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2021	31 Dec 2022
Disclosure	Profit only	Profit only
Profit & loss
Revenue (turnover)	—	—
Profit after tax	£83.2k	£603k
Profit (best available)	£83.2k	£603k
Employees (average)	4	2
Ratios
Profit margin	—	—
Profit per employee	£20.8k	£302k
Growth (year on year)
Profit growth	—	▲625.4%
Headcount growth	—	▼50%
Balance sheet — indirect signals, not revenue
Cash at bank	£48.7k	£162k
Net assets	£995k	£1.6m
Current assets	£2m	£2.8m
Debtors	£399k	£233k
Source	Accounts · bulk data Dec 2023	Accounts · bulk data Dec 2023

Derived from the latest filing

How the business works

Profit margin: —; Profit ÷ revenue.
Gross margin: —; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: £302k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲61%; Now £1.6m
Cash at bank: ▲232%; Now £162k
Headcount: ▼50%; Now 2
Deferred income: —; Now —
Fixed assets: —; Now —

Corporate ownership

Group structure

Ownership chain

Ennogen Holdings Limitedultimate parent75–100%
Ennogen Pharma Ltdthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (2)

Ennogen Healthcare LtdRev. — · Profit £1.1m
Ennogen Investments LtdRev. — · Profit −£3k

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from accounts for the year to 31 Dec 2022 (profit £603k), from the Companies House accounts bulk data published Dec 2023. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.